About Journal

About Journal

TMR Cancer is a  the official journal of the China Anti-Cancer Association (中国抗癌协会). It has been included in a variety of databases, including the  ScienceOpen database, VIP database, CNKI Scholar, Superstar database, and Google Scholar.

TMR Cancer is one of the TMR series of journals focused on oncology research. 

Aims & Scope

TMR Cancer focuses on the publication of innovative, scientific medical papers and set up basic research, clinical research, case reports, comment, review, theoretical discussion, drug research columns. Areas that are relevant to traditional Chinese medicine and modern medicine are of interest. This journal mainly reports the research progress and discusses the idea and method of cancer, carries on the scholarly discussion. It provides readers with the experience and idea of cancer therapy. Encourage research and sort TM by using modern scientific methods. As the sister journal of Traditional Medicine Research, TMR Cancer pays more attention to integrative medicine.

Content and column 
Original Articles
Case Reports
Medical Hypotheses

Key topics
Treatment strategies
Evaluations of current therapies
Models for integrating complementary and conventional treatment in clinical practice
Interventions from alternative and traditional medicine
Implementing quality-of-life assessment and counseling in the clinical setting
Cancer rehabilitation during and following cancer treatments
Potential interactions of drugs with frequently used dietary supplements
Implementing integrative cancer care strategies into oncology practice
Relevant molecular mechanisms and biology behind integrative approaches
Impact of timing of chemotherapy administration on toxicity, response, and outcome

TMR Cancer focuses on the following areas:
1. Traditional Chinese medicine and local specialty medicine related oncology
2. Integrated traditional Chinese and Western medicine oncology
3. The molecular diagnosis of and targeted molecular or precision therapy for all types of cancer.
4. Cancer epidemiology
5. Cancer biomarkers
6. Mechanisms of drug sensitivity and resistance
7. Cancer Genetics, Cancer and stem cell biology, Molecular and clinical immunology

At the same time, we pay attention to the comparison of traditional medicine and western medicine on the understanding, treatment, and treatment of cancer.

Peer review policy

TMR cancer follows a double-blind peer review process, to ensure impartial editorial decision-making. All submissions to TMR cancer are assessed by an editor, who will decide whether they are suitable for peer review. If an editor is on the author list or has any other competing interest regarding a specific manuscript, another member of the Editorial Board will be assigned to assume responsibility for overseeing peer review. Submissions felt to be suitable for consideration will be sent for peer review by appropriate independent experts. Editors will make a decision based on the reviewers’ reports and authors are sent these reports along with the editorial decision on their manuscript. Authors should note that even in light of one positive report, concerns raised by another reviewer may fundamentally undermine the study and result in the manuscript being rejected.


Peer reviewers

Authors may suggest potential reviewers if they wish; however, whether or not to consider these reviewers is at the editor's discretion. Authors should not suggest recent collaborators or colleagues who work in the same institution as themselves. Authors who wish to suggest peer reviewers can do so in the cover letter and should provide institutional email addresses where possible, or information which will help the editor to verify the identity of the reviewer.

Authors may request the exclusion of individuals as peer reviewers, but they should explain the reasons in their cover letter on submission. Authors should not exclude too many individuals as this may hinder the peer review process. Please note that the editor may choose to invite excluded peer reviewers.

Intentionally falsifying information, for example, suggesting reviewers with a false name or email address, will result in rejection of the manuscript and may lead to further investigation in line with our misconduct policy.



Reviewers are therefore required to respect the confidentiality of the peer review process and not reveal any details of a manuscript or its review, during or after the peer-review process, beyond the information released by the journal. If reviewers wish to involve a colleague in the review process they should first obtain permission from the journal. The editor should be informed of the names of any individuals who assisted in the review process when the report is returned.


Annual Advances

TMR Data ExpandedMore